n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Heart Failure in 3 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "ACF induced cardiac hypertrophy in rats with compensated (36%) and decompensated (76%) HF." | 1.31 | Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure. ( Abassi, Z; Binah, O; Gealekman, O; Rubinstein, I; Winaver, J, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, P | 1 |
| Xu, X | 1 |
| Hu, X | 1 |
| van Deel, ED | 1 |
| Zhu, G | 1 |
| Chen, Y | 1 |
| Gealekman, O | 1 |
| Abassi, Z | 1 |
| Rubinstein, I | 1 |
| Winaver, J | 1 |
| Binah, O | 1 |
| Heusch, P | 1 |
| Aker, S | 1 |
| Boengler, K | 1 |
| Deindl, E | 1 |
| van de Sand, A | 1 |
| Klein, K | 1 |
| Rassaf, T | 1 |
| Konietzka, I | 1 |
| Sewell, A | 1 |
| Menazza, S | 1 |
| Canton, M | 1 |
| Heusch, G | 1 |
| Di Lisa, F | 1 |
| Schulz, R | 1 |
3 other studies available for n-(3-(aminomethyl)benzyl)acetamidine and Heart Failure
| Article | Year |
|---|---|
Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure.
Topics: Amidines; Animals; Aortic Diseases; Atrial Natriuretic Factor; Benzylamines; Cardiomegaly; Chronic D | 2007 |
Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure.
Topics: Adrenergic beta-Agonists; Amidines; Animals; Arteriovenous Fistula; Benzylamines; Calcium; Cardiac V | 2002 |
Increased inducible nitric oxide synthase and arginase II expression in heart failure: no net nitrite/nitrate production and protein S-nitrosylation.
Topics: Animals; Arginase; Arginine; Blotting, Western; Cardiac Pacing, Artificial; Disease Models, Animal; | 2010 |